DiaSorin S.p.A (DSRLF PINK) stock market data APIs
$107.6746
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
DiaSorin S.p.A Financial Data Overview
Price chart is built with
Anychart
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Prev. Close
107.6746
Open
107.6746
High
107.6746
Low
107.6746
52 wk Range
100.01-112.3
Market Cap
5 856 M
P/E Ratio
26.6978
Shares Outstanding
53 892 K
Revenue
1 209 M
EPS
1.14
Dividends (Yield)
0.0126
Beta
0.247
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DiaSorin S.p.A data using free add-ons & libraries
Get DiaSorin S.p.A Fundamental Data
DiaSorin S.p.A Fundamental data includes:
- Net Revenue: 1 209 M
- EBITDA: 374 M
- Earnings Per Share: 4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2022-10-27
- EPS/Forecast: 0.9
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DiaSorin S.p.A News
New
Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies
Company Logo The Europe proteomics market is expected to rise to $27.43 billion by 2034 from $8.77 billion in 2024, with a CAGR of 12.07%. Driving this growth are advancements in mass spectrometry an...
Diasorin SpA (DSRLF) Full Year 2024 Earnings Call Highlights: Resilient Performance Amid Global ...
Release Date: March 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Diasorin SpA (DSRLF) reported revenue and profitabi...
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
Cytek Biosciences, Inc. Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven...
BrainStorm Announces Presentation of NurOwn® Exosome Preclinical Data at ISCT 2022 San Francisco Meeting
NurOwn-derived exosomes showed more potent anti-inflammatory effects in vitro compared to naïve mesenchymal stem cell-derived exosomes NEW YORK, May 4, 2022 /PRNewswire/ -- BrainStorm Cell Therapeut...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
